The Fort Worth Press - Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

USD -
AED 3.672504
AFN 66.503991
ALL 80.629676
AMD 365.091035
AOA 917.000367
ARS 1491.937897
AUD 1.417435
AWG 1.80125
AZN 1.70397
BAM 1.691649
BBD 2.00813
BDT 123.418242
BHD 0.375989
BIF 2985.079791
BMD 1
BND 1.277602
BOB 11.849673
BRL 5.083304
BSD 0.997016
BTN 94.875232
BWP 13.457596
BYN 2.968819
BYR 19600
BZD 2.00519
CAD 1.39545
CDF 2262.50392
CHF 0.80949
CLF 0.023206
CLP 913.315746
CNY 6.747604
CNH 6.743285
COP 3142.844787
CRC 453.228387
CUC 1
CUP 26.5
CVE 95.372573
CZK 20.982104
DJF 177.546166
DKK 6.46804
DOP 58.20179
DZD 132.308956
EGP 49.631449
ERN 15
ETB 160.923669
EUR 0.86495
FJD 2.20855
FKP 0.74148
GBP 0.742583
GEL 2.610391
GGP 0.74148
GHS 11.700039
GIP 0.74148
GMD 73.503851
GNF 8756.649224
GTQ 7.607144
GYD 208.588851
HKD 7.84315
HNL 26.723176
HRK 6.518804
HTG 130.363707
HUF 314.060388
IDR 17801
ILS 2.99985
IMP 0.74148
INR 95.210504
IQD 1306.058902
IRR 1375550.000352
ISK 123.340386
JEP 0.74148
JMD 158.335856
JOD 0.70904
JPY 157.80604
KES 129.014401
KGS 87.450384
KHR 4049.647537
KMF 426.00035
KRW 1407.860383
KWD 0.30866
KYD 0.830861
KZT 467.275008
LAK 22510.919863
LBP 89282.792025
LKR 334.420274
LRD 179.959348
LSL 16.197552
LTL 2.95274
LVL 0.60489
LYD 6.341738
MAD 9.29222
MDL 17.337716
MGA 4254.638239
MKD 53.215413
MMK 2099.549369
MNT 3595.852714
MOP 8.056654
MRU 40.080439
MUR 47.070378
MVR 15.450378
MWK 1728.841413
MXN 17.13645
MYR 4.090104
MZN 63.905039
NAD 16.197552
NGN 1364.860377
NIO 36.690741
NOK 9.51237
NPR 151.800372
NZD 1.701115
OMR 0.382693
PAB 0.997016
PEN 3.376465
PGK 4.406003
PHP 60.705038
PKR 276.796523
PLN 3.719205
PYG 5928.296501
QAR 3.644596
RON 4.536304
RSD 101.492021
RUB 81.598409
RWF 1466.072741
SAR 3.755591
SBD 8.065696
SCR 14.449077
SDG 600.503676
SEK 9.480804
SGD 1.278038
SLE 24.603667
SOS 569.822255
SRD 37.866504
STD 20697.981008
STN 21.191022
SVC 8.723782
SZL 16.194265
THB 33.050369
TJS 9.197509
TMT 3.51
TND 2.929032
TRY 47.697504
TTD 6.757774
TWD 32.250604
TZS 2639.622886
UAH 44.653894
UGX 3714.050945
UYU 40.133201
UZS 11924.058297
VES 755.762404
VND 26204.5
VUV 118.557141
WST 2.733716
XAF 567.363231
XAG 0.015731
XAU 0.00023
XCD 2.70255
XCG 1.796912
XDR 0.705618
XOF 567.363231
XPF 103.152705
YER 238.403589
ZAR 16.14632
ZMK 9001.203584
ZMW 18.818492
ZWL 321.999592
  • CMSC

    0.0240

    21.744

    +0.11%

  • RIO

    1.4500

    101.1

    +1.43%

  • BCC

    2.3400

    86.6

    +2.7%

  • RBGPF

    0.7600

    70.5

    +1.08%

  • BCE

    -0.0200

    22.75

    -0.09%

  • GSK

    0.7900

    52.96

    +1.49%

  • RYCEF

    0.2300

    20.85

    +1.1%

  • BTI

    0.6000

    59.33

    +1.01%

  • AZN

    1.4100

    161.42

    +0.87%

  • NGG

    0.4700

    80.88

    +0.58%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • JRI

    0.1500

    12.81

    +1.17%

  • RELX

    0.0485

    35.52

    +0.14%

  • BP

    -0.6000

    41.63

    -1.44%

  • VOD

    0.1900

    16.19

    +1.17%

Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic
Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

Rapid advances in artificial intelligence may create new opportunities for MDCE to expand technical capability while accelerating execution across its AI platform initiatives.

Text size:

MESA, AZ / ACCESS Newswire / May 19, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), an emerging artificial intelligence and imaging technology company, today announced a strategic evaluation of next-generation AI infrastructure and multimodal vision systems following major advancements from industry leaders NVIDIA and Anthropic that may materially accelerate the Company's AI commercialization roadmap.

Recent breakthroughs in artificial intelligence have materially shifted the competitive landscape.

Anthropic's newly introduced Claude Opus 4.7, capable of processing images up to 2,576 pixels on the long edge-more than 3x prior Claude vision models- alongside major advances in multimodal reasoning, agentic automation, and NVIDIA's next-generation compute infrastructure, may create advanced opportunities for MDCE to dramatically expand technical capabilities without the historical burden of building on foundational infrastructure.

MDCE's AI ecosystem spans consumer, enterprise, and imaging-driven initiatives, including:

  • Preventive health and imaging analysis technologies under development (MDCE Melanoma Scan Beta)

  • Real Game Used - AI memorabilia authentication imaging intelligence (Active)

  • Future enterprise-grade visual intelligence applications (TBA)

  • Snapshot Recipes - AI-powered food recognition, ingredient analysis, and intelligent recipe generation (Live)

For a company focused on imaging analysis, the leap in visual processing capability is particularly meaningful.

Higher-resolution multimodal AI systems may materially enhance object recognition accuracy, scene interpretation, contextual analysis, visual comparison workflows, and enterprise-scale image intelligence-capabilities directly aligned with MDCE's evolving AI pipeline.

This acceleration has prompted management to evaluate whether leveraging newly available AI infrastructure from global technology leaders may create greater shareholder value than certain legacy development pathways conceived prior to the current AI acceleration cycle.

As part of this strategic review, MDCE is also evaluating whether transitioning elements of its existing provisional intellectual property portfolio into non-provisional patent filings remains the optimal path, or whether integrating next-generation commercial AI ecosystems may provide a faster and more capital-efficient route to commercialization.

"AI capabilities have evolved at an extraordinary pace," said Marshall Perkins, CEO of Medical Care Technologies. "When visual AI systems suddenly gain materially stronger image interpretation capabilities and hyperscale infrastructure becomes increasingly accessible, agile companies must reassess execution strategy in real time."

"This is not a defensive adjustment. This is a strategic offensive evaluation designed to align MDCE with the strongest AI infrastructure currently available and accelerate our path toward commercialization, scalability, and shareholder value creation."

About Medical Care Technologies:
 Medical Care Technologies Inc. (OTC Pink:MDCE) is an emerging technology company focused on the development and commercialization of innovative AI-driven applications across lifestyle, wellness, and consumer markets, with Snapshot Recipes representing its first major consumer-facing platform. The company also operates a portfolio of subsidiaries, including Infinite Auctions, an online marketplace specializing in high-end sports memorabilia and collectibles, and Real Game Used (RGU), a proprietary authentication platform leveraging advanced methodologies, including AI-driven image analysis, to verify game-used memorabilia. Through the integration of artificial intelligence, digital platforms, and strategic marketing initiatives, Medical Care Technologies is positioning itself for scalable growth while expanding its presence across both consumer technology and high-value asset markets.

Contact Info:

X account: https://x.com/medicalcaretech
Company Website: https://medicalcaretechnologies.com/

MEDICAL CARE TECHNOLOGIES INC.
1910 S Stapley Drive
Suite 221
Mesa, AZ 85204
[email protected]
+1 480-645-0750

Safe Harbor Statement: This press release contains forward-looking statements, including statements regarding artificial intelligence initiatives, product development, beta technologies, commercialization opportunities, intellectual property strategy, and potential integrations with third-party AI infrastructure. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially, including technological feasibility, development timelines, regulatory considerations, market conditions, capital availability, competitive factors, commercialization execution, and third-party platform access. References to NVIDIA, Anthropic, or other third-party technologies do not imply partnership or endorsement unless expressly stated. The Company undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire

J.Barnes--TFWP